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Introduction
Harm done by alcohol
Alcohol is a cause of a wide range of diseases and injuries, exac-
erbated by occasions of heavy drinking1, resulting in it ranking as 
the ninth leading global risk-factor in 2015 for morbidity and pre-
mature death2. Ranking increases to fourth in Colombia and Peru, 
and fifth in Mexico2, the three Latin American countries addressed 
in this protocol.
The clinical condition of alcohol use disorder (AUD)3–5, 
which includes the harmful use of alcohol, is associated with 
considerable disability, morbidity, and mortality6,7. Worldwide in 
2015, there were 63.5 million cases of AUD8 (due to more restric-
tive definitions, this is lower than other estimates of 95 million 
cases9), responsible for 137,500 deaths10, 6.3 million years lived 
with disability8, and 112 million disability adjusted life years11.
Sustainable development goals
Adverse impacts from AUD and the harmful use of alcohol are 
aggravated by lower socio-economic status12. Impacts also extend 
beyond the individual drinker, with considerable costs borne by 
families, communities, health systems, and the wider economy7. A 
large proportion of these costs are avertable13. Tackling the multiple 
individual and societal level harms caused by AUD and the harm-
ful use of alcohol is a global economic and public health priority, 
and essential for achieving global targets of reducing deaths from 
non-communicable diseases by 25% between 2010 and 202514, 
more so as risk of exposure to harmful use of alcohol increases 
with increasing socio-economic status in low and middle income 
countries2. Further, building on the global NCD framework15 and 
the WHO global strategy16, UN Sustainable Development Goals 
Target 3.5 is to strengthen the prevention and treatment of substance 
abuse, including narcotic drug abuse and harmful use of alcohol, 
with two proposed indicators: coverage of treatment interventions 
(pharmacological, psychosocial and rehabilitation and aftercare 
services) for substance use disorders (including AUD); and, per 
capita alcohol consumption17.
Heavy drinking
This protocol focuses on the prevention and management of heavy 
drinking, an understandable term to use when identifying at risk 
patients in primary health care (PHC)18–21. We base our definition 
of heavy drinking on the European Medicines Agency’s ‘threshold 
1’, more than 60g of alcohol consumed on average a day by a man 
and more than 40g a day by a woman22. These are the same levels as 
original descriptions used in global burden of disease studies23. For 
practical purposes, we take the mid-point (50g a day) as our defini-
tion of heavy drinking. At this level of consumption, there is little 
difference in absolute risk (about 3.5%) of dying prematurely due 
to alcohol before the age of 70 years between men and women24.
Advice and treatment gap
Despite the fact that heavy drinking is one of the most impor-
tant modifiable causes of premature morbidity and mortality25, 
worldwide, although the data should be interpreted with caution, it 
is estimated by WHO that as many as four out of five heavy drink-
ing individuals fail to receive the offer of appropriate advice or 
treatment26,27. In Mexico, the gap is nine out of ten28,29. The problem 
is not one of lack of effective treatment and prevention options30,31. 
A robust and extensive body of literature demonstrates the range 
of evidence-based strategies available to policy makers and practi-
tioners seeking to reduce heavy drinking31,32. Questionnaire-based 
screening and brief advice programmes delivered in PHC are 
effective33 and cost-effective34 in reducing heavy drinking, even 
though the extent to which this evidence-base is grounded in effi-
cacy (ideal world) or effectiveness (real world) trials is still debated 
in some academic circles35. In addition to brief advice, treatment 
for AUD and harmful alcohol use include cognitive behavioural 
therapy and pharmacotherapy, both of which are found to be effec-
tive in reducing heavy drinking36–39. However, to date at least, these 
have failed to achieve widespread up-take31,40,41.
The Organisation for Economic Co-operation and Development 
(OECD) has estimated that if the proportion of eligible patients 
receiving advice and treatment for heavy drinking increased 
to 30% of eligible patients, the prevalence of harmful use of 
alcohol could decrease by as much as 10–15% across OECD 
member countries, with reductions in the annual incidence of 
AUD of 5–14%40. Large scale implementation of advice and 
treatment programmes can be expensive because of staff and 
drug costs, but has the potential of large reductions in health care 
expenditures, with, in some countries, advice and treatment pro-
grammes estimated to be cost saving by large margins40. Such 
programmes would also free large numbers of working age people 
per year from alcohol-related diseases.
Increasing PHC activity
Two systematic reviews42,43 and two multi-country studies41,44,45 
have demonstrated the possibility of increasing the proportion of 
patients screened, and screen-positive patients given advice by their 
PHC providers. The WHO Phase III four-country study on the iden-
tification and management of alcohol-related problems in primary 
care found that the odds ratios for the impact of training and sup-
port on increasing higher screening proportions (defined as 20% or 
more of eligible patients screened) was 2.2 (95% CI=1.3 to 3.1) 
and on increasing higher intervention proportions (defined as 
            Amendments from Version 2
The title of the paper has been changed in two ways: first, 
replacing alcohol use disorder with heavy drinking, as the focus 
of the intervention is heavy drinking; changing pre-protocol 
to protocol, as the study is now funded by the Horizon 2020 
programme of the European Commission.
We have shortened the first five paragraphs of the Introduction, 
deleting detail of descriptions of different nomenclature related to 
clinical diagnoses.
We have replaced EuroQol with WHODAS 2.0 as our measure 
of health and disability, as WHODAS 2.0 is a more generic and 
global instrument.
We have revised Figure 4.
We have added patient alcohol health literacy and injunctive 
social norms as a secondary outcome measure.
We have updated the Grant information section.
See referee reports
REVISED
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10% or more of eligible patients screened and advice given to 
screen positives) was 2.8 (95% CI = 1.6 to 4.0), albeit from very 
low baseline levels45. In the more recent five-country European 
ODHIN (Optimizing Delivery of Health Care Interventions) 
study, providing training and support to PHC providers increased 
the number of patients screened by 50%, and providing finan-
cial reimbursement to PHC providers increased the number of 
patients screened by 100%, also from low baseline levels of 6/100 
consulting adult patients screened41. Other evidence has suggested 
that the impact of financial incentives on screening and brief 
alcohol advice in England might have limited effects46. Although 
incentivised practices recorded higher levels of activity than those 
not paid to deliver alcohol interventions, overall rates of delivery 
remained low.
Most work has been undertaken in high-income countries. Whilst 
there has been some work in low- and middle-income countries47, 
including countries of Latin America48–53, there is an opportunity to 
fast-track scale-up research and practice in such countries.54 
Overcoming constraints on PHC activity
To date, impacts in increasing PHC provider activity have been 
modest55. There are two important possible reasons for this, 
which we address in this protocol. The first reason is that standard 
cut-offs for the frequently used screening instrument, AUDIT-C56 
(commonly five for both men and women, or five for men and four 
for women) to trigger advice are too low, being equivalent to an 
average daily alcohol consumption of about 20g of alcohol or less57. 
Practitioners may well find themselves averse to intervening at such 
low levels, which would also have huge resource implications, with 
one in three or four patients being eligible for advice. Cut-off points 
for managing raised blood pressure are commonly determined 
by levels of blood pressure at which treatment has shown to be 
effective58. Similarly, cut-off points for brief advice could be the 
baseline levels of alcohol consumption found in the randomized 
controlled trials that have investigated the effectiveness of PHC 
delivered brief advice. In the first Cochrane review of the topic, 
when reported, baseline levels ranged from 89 to 456g per week, 
with an overall mean across trials of 313g per week59. At a mean 
of 313g per week (45g per day, a little lower than the definition of 
heavy drinking, 50g of alcohol per day, given above), the equivalent 
AUDIT-C cut off would be 857. That lower cut-offs may be inap-
propriate is also illustrated by the lower effect sizes found in an 
updated Cochrane review, where the average baseline consump-
tion at enrolment had dropped to 183g/week60. It has also been 
suggested that PHC providers might be more engaged in screen-
ing and giving brief advice, if screening were targeted to patients 
with comorbid conditions, such as depression or hypertension30,61,62. 
However, to date, there is insufficient evidence for an appropriate 
package that deals with comorbidity to scale-up63. Further, it has 
been shown that targeted screening misses out on the vast major-
ity of patients that would be captured by universal screening64. 
Given the strong associations between harmful alcohol use and 
depression65,66, our protocol includes screening for depression 
and appropriate PHC-based management67–69 or referral for those 
patients identified as screen positive by AUDIT-C.
The second reason for modest increases in PHC-based activity 
could be due to a focus on providers alone, whereas successful 
implementation of health interventions within complex health sys-
tem demands addressing a range of underlying structural and sup-
port systems70. Phase IV of the WHO study on the identification 
and management of alcohol-related problems in primary care71, 
outlined a range of conclusions for enhancing the widespread 
uptake of screening and brief advice programmes to reduce the 
harmful use of alcohol: (i) training and practice-based materi-
als need local customization that can be achieved through focus 
groups; (ii) reframing views about alcohol of both professionals 
(through training) and the public (through mass media campaigns) 
is essential; (iii) the establishment of a lead organization is essen-
tial, gathering endorsements from a range of organisations and 
individuals that are highly relevant to the aims of the work; and 
(iv) adequately controlled community-based studies need to be 
undertaken to strengthen the evidence base for achieving routine 
implementation71. The WHO Phase IV study concluded that 
embedding PHC-based screening and brief advice programmes 
within the  frame of supportive community and municipal envi-
ronments might lead to improved outcomes. Experience from 
the US-based SAMHSA SBIRT initiative72 stressed the impor-
tance of local champions and whole practice buy in for successful 
implementation73,74.
This protocol outlines the design of a quasi-experimental study 
to test the scale-up of PHC based screening and brief advice pro-
grammes to reduce heavy drinking at city level in three Latin 
American middle-income countries75 (Colombia, Mexico and 
Peru), in which the prevalence of AUD is 6, 7 and 3%, respectively, 
and the prevalence of heavy episodic drinking is 4, 11 and 12%, 
respectively4. We will base our action on the Institute for Health-
care Improvement’s (IHI) framework for ‘going to scale’, which 
designates four steps in a sequence: (1) Set-up, which prepares the 
ground for introduction and testing of the intervention that will be 
taken to full scale; (2) Develop the Scalable Unit, which is an early 
testing phase; (3) Test of Scale-up, which then tests the interven-
tion in a variety of settings that are likely to represent different 
contexts that will be encountered at full scale; and (4) Go to Full 
Scale, which unfolds rapidly to enable a larger number of sites or 
divisions to adopt and/or replicate the intervention70, see Figure 1. 
We call the proposed study SCALA (Scale-up of Prevention and 
Management of Alcohol Use Disorder in Latin America).
Aim and objectives
Driven by implementation science70,76–83, this three-country 
study aims to test the extent to which embedding PHC-based 
screening and brief advice activity within supportive municipal 
action leads to improved scale-up of more patients with heavy 
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drinking receiving appropriate advice and treatment. The study 
has the following objectives: 
1.   To deliver a tailored package for improving prevention and 
early identification of heavy drinking, with advice and treat-
ment for case positives that is scalable at municipal level in 
a wide range of middle- income countries;
2.   To set-up and implement the scalable package with key 
stakeholders in three case study cities (scalable units) from 
Colombia, Mexico and Peru;
3.   To test the scale-up of the package for its impact on provider 
delivery of early identification and management;
4.   To identify and document the facilitators and barriers, and 
the organizational and resource requirements for going to 
full-scale, including full economic analyses; and
5.   To present a validated framework and strategy for going to 
full-scale, embedding the package into routine policy and 
practice, taking into account aspects of stigmatization and 
equity, that can be replicated globally in the future through-
out municipalities.
Our hypothesis is that, by embedding the primary health care action 
in a community and municipal setting with added support will lead 
to a greater proportion of patients screened and advised for heavy 
drinking than achieved hitherto in implementation studies that 
focused on providers alone.
Countries from Latin America are selected as this is a sub-region 
of the world in which alcohol jumps from ninth globally to the 
fourth most important risk factor for morbidity and premature 
death14. The three specific middle-income countries are chosen 
to represent Central (Colombia and Mexico) and Andean (Peru) 
Latin America. The three countries have pre-existing collaboration 
between the authors, who have experience in the area48–53.
Protocol
Design
The study is a quasi-experimental design84, comparing changes in 
screening and brief advice, and, if relevant, referral for treatment 
activity, amongst primary health care units (PHCUs) in intervention 
cities with PHCUs in similar control cities, Figure 2.
Cities
Intervention municipalities that have confirmed technical and 
political consent to be involved have been investigator-selected 
from Bogotá (Colombia), Mexico City (Mexico) and Lima (Peru). 
Comparator municipalities have been investigator-selected in 
Bogotá, Mexico City and Lima, on the basis of comparability with 
the scale-up municipality in terms of socio-economic and other 
characteristics which impact on drinking, health care and survival, 
comparable community mental health services, and sufficient geo-
graphical separation to minimize spillover effects from the inter-
vention municipality. Randomized selection of the municipalities 
was excluded as the hypotheses and the study approach relies on 
municipal-level interventions. Cities are chosen as the scalable unit, 
as there is a systemic global trend for municipalities to increas-
ingly take on the jurisdictional responsibilities for prevention and 
health care services. Cities, themselves, are active in prevention 
and health promotion programmes, and there is a strong evidence 
Figure 1. Sequence of activities for going to scale. The four phases of going to scale from setting up the programme within the three cities 
to exploiting the validated framework and strategy through city networks, with the adoption mechanisms and support systems. PHC, primary 
health care.
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base for their impact, also in the prevention of alcohol-related 
harm85,86. Cities are a natural site for preventing alcohol-related 
harm87. Although not having the full jurisdictional responsibilities 
of national governments for all alcohol policy issues, they often 
have greater flexibility and are an important site for both media-
based and social norms programmes, as well as environmental 
measures to manage and limit availability of alcohol88. Networks 
of cities are natural vehicles for exploitation of the results and 
deployment to full scale, more so with the trends of increasing 
urbanization in Latin America89,90.
Primary health care
Primary care-focused health initiatives can improve access to 
health care, including among the poor, at reasonably low cost in 
low- and middle-income countries91, and particularly so in Latin 
America90. Health-system reforms in Latin America have placed 
a strong emphasis on the development of comprehensive PHC as 
a vehicle to achieve universal health coverage, reduce inequities, 
and democratise health through participation. However, they 
face ongoing challenges, in particular, the development of health 
services that can meet the emerging health needs brought on by 
social and demographic transitions, including the increasing 
chronic disease burden, and the impacts of rapid urbanisation92.
Management of chronic diseases relies on opportunistic case 
finding, assessment of risk factors, detection of early disease, iden-
tification of high-risk status, combined psychosocial and phar-
macological interventions, and long-term follow-up with regular 
monitoring and promotion of adherence to advice and treatment. 
Such approaches are financially feasible and have the potential to 
substantially reduce the burden of chronic diseases. Many inter-
ventions can be managed effectively by non-specialists and lay 
health care workers who are supported by specialists. Although 
implemented in a range of settings, collaborative care models 
seem best delivered in PHC settings93. Evidence demonstrates the 
effectiveness of PHC-based lifestyle interventions in Latin 
American contexts94,95, including brief advice programmes to 
reduce heavy drinking, as well as the potential to detect and 
refer high-risk patients.
Participants
Approximately ten PHCUs per intervention and comparator 
cities will be involved, 60 PHCUs in total. The exact number of 
PHCUs will depend on the average number of registered patients 
per PHCU. In each city, the total number of recruited PHCUs 
should cover a population of about 80,000 registered patients 
(including children and adults). In jurisdictions, where PHC phy-
sicians work as individual practitioners, a PHCU can be defined 
for the purposes of the study as a virtual or physical location 
where three or more PHC physicians work. Identification of 
PHCUs who agree to participate in the studies will be drawn from 
administrative or academic registries of PHCUs at national, 
regional, or city levels. The process of recruiting PHCU will be 
described in detail by each country. Within each PHCU, eligible 
providers will include any fully trained medical practitioner, nurse 
or practice assistant with a non-temporary employment contract, 
working in the PHCU and involved in medical and/or preven-
tive care. These providers will sign an informed consent for their 
participation. Dependent on customary country practice, participat-
ing PHCUs will receive a study fee.
Figure  2.  Study  design  and  flow  for  the  three  scale-up  cities  and  the  three  comparator  cities,  with  data  gathered  during  each 
measurement period. PHCU, primary health care unit.
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SCALA care pathway for heavy drinking
The SCALA care pathway includes three integrated components: 
  i.   preventing the development of heavy drinking via increased 
alcohol health literacy;
 ii.   screening and brief advice to reduce the prevalence of heavy 
drinking; and
iii.   diagnosis and clinical management of severe AUD and/or 
co-morbid depression.
The SCALA intervention package deals primarily with the first 
two parts, prevention and management of heavy drinking. It 
does not specifically address managing severe AUD, including 
alcohol-related physical complications and/or severe co-morbid 
mental health conditions, but ensures the necessary links with 
specialist services in order to do so, even though specialist 
treatment can be managed in PHC, with appropriate support67,96.
Whilst AUDIT-C is highly effective at identifying heavy drink-
ing, it is not designed to stratify patients by severity of AUD, nor 
designed to diagnose depression, commonly comorbid with heavy 
drinking. A DSM-5 11-item instrument can be used to stratify the 
severity of AUD into mild (2–3 items), moderate (4–5 items) and 
severe (6+ items)97. Similarly, the Patient Health Questionnaire 
9 (PHQ-9), can be used to diagnose moderately severe or severe 
depression with a cut-off score of 15+98. In our protocol, patients 
scoring 8+ on AUDIT-C, will be further screened with the DSM-5 
11-item instrument and the PHQ-9 to assess severity of AUD and to 
identify patients with co-morbid depression.
For the care pathway (Figure 3), all adult patients (age 18+ years) 
visiting the PHCU for whatever reason will be screened with 
AUDIT-C, with country-specific pictograms of standard alcohol 
beverages used to identify the standard unit (drink) of alcohol. 
Patients with an AUDIT-C score of <8 will be given a patient infor-
mation leaflet to improve alcohol health literacy (knowledge of 
the risks of drinking alcohol, and skills to achieve and maintain 
lower risk drinking, defined as no more than 20g of alcohol per 
day). Patients with an AUDIT-C score of 8+ will be invited to 
complete the DSM-5 11-item instrument and the PHQ-9: those 
with an 11-item score of <6 and a PHQ-9 score of < 15 will be 
given brief advice of between 5–10 minutes, based on the FRAMES 
principles99. Those with an 11-item score of 6+ and/or a PHQ-9 
score of 15+ will be refereed to more specialist services, at the 
clinical decision of the health care provider A record of what 
steps are taken will be recorded on paper or electronic tally sheets 
prepared for the study.
Implementation strategies
In the intervention cities, implementation strategies will comprise 
three components: tailoring the PHC screening and advice 
Figure 3. Comprehensive care pathway of SCALA. For screen negative patients, screen positive patients without AUD and depression and 
for screen positive patients with AUD and/or depression. PHCU, primary health care unit; AUD, alcohol use disorder.
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package; providing specific practice-based training and ongoing 
support to PHCUs; and, implementing city-based adoption 
mechanisms and support systems, including media-based cam-
paigns to improve alcohol health literacy. In the intervention cities, 
all PHCUs will be given a summary card of screening and advice 
procedures, with instruction, instruction on how to complete record 
sheets, and record sheets. In the control cities, all PHCUs will 
be given a summary card of screening and advice protocol, with 
no instruction, instruction on how to complete record sheets, and 
record sheets. As part of the study, no other action will take place 
in the control cities.
Tailoring PHC screening and advice package
SCALA is a trans-cultural study, with different health systems, 
and differences in drinking patterns and attendance at PHC 
centres, compounded by gender differences. In Mexico, for 
example, men consume more alcohol then women, but attend PHC 
services much less frequently than women53. Thus, there is a need 
for careful tailoring of the screening and advice package. Each 
intervention city will create Community Advisory Boards (CABs) 
representing academia, city health and public health departments, 
health service commissioners and practitioners, and patient and 
public engagement groups; and User Panels (UPs) of user groups, 
including PHC providers, patients and citizens. Through expert 
meetings, workshops, and focus groups, the package will be fine-
tuned and tailored to the needs of each city, based on the Tailored 
Implementation for Chronic Diseases initiative100–102 within the 
seven domains of: local and national guideline factors; individual 
health care provider factors; patient factors; interactions between 
different professional groups; incentives and resources; capac-
ity for organizational change; and, social, political and legal fac-
tors. At the city level, tailoring will be based on the principles of 
integration between PHC and municipal services103 and the devel-
opment of complementary community ecosystems that support 
reductions in heavy drinking. At the PHC level, tailoring will 
be based on the principles of co-production of health104 between 
PHC providers and patients.
Training and ongoing support of PHCUs
In the intervention cities, PHCUs will be offered two initial 
two-hour face-to-face educational trainings prior to the 18-month 
scale-up phase, and two one-hour booster sessions during the 
first twelve months of the 18-month scale-up phase. Training 
will take place within the PHCU or clusters of PHCUs. Training 
will be undertaken by peer trainers, members of the research team, 
accredited teachers, or addiction consultants. Training will focus 
on management and administrative skills within the primary health 
care center, on practical skills in undertaking screening and in 
delivering brief advice, in using the questionnaires, and in 
knowing when and how to refer patients with more severe 
AUD105–108 and moderately severe or severe depression to 
available services, such as community-based mental health 
and addiction centers67. Training will, in addition, address 
attitudes, and perceived barriers and facilitators109–111 in 
implementing screening and brief advice, contextualized to local 
circumstances112. Each country will use an adapted existing 
country-based training and support package. Where these do not 
exist, training and support packages will be adapted based on the 
PHEPA (Primary Health Care European Project on Alcohol) 
training programme113, widely implemented since 2002 in Cata-
lonia, a Catalan/Spanish speaking, bilingual geographic area. The 
PHEPA training programme is similar to those used in the WHO 
Phase III trial45 and the ODHIN study41.
Implementing city-based adoption mechanisms and 
support systems
Within each intervention city, an integrator (champion and knowl-
edge and practice broker) will be appointed with responsibilities of 
serving as a trusted and accountable leader: facilitating agreement 
within the city and health systems on shared goals and metrics; 
assessing and acting on relevant community resources; working 
at the systems level to make relevant practice changes for sustain-
ability; gathering, analyzing, monitoring, integrating, learning, and 
sharing data at the individual PHCU and city levels; identifying and 
connecting with system navigators who help PHCUs coordinate, 
access, and manage multiple services and supports; and developing a 
system of ongoing and intentional communication with PHCUs and 
cities.
Within each intervention municipality, the Community Advi-
sory Boards will identify adoption mechanisms that can be used 
for scale-up, for example: (i) demonstration of the superiority of 
the PHC package, its simplicity, and its alignment with the lat-
est evidence of preventing and managing heavy drinking and 
of implementation science; (ii) engagement of identified lead-
ers and building their capacity to lead and ensure broad adoption 
of the PHC package through guiding and supporting large-scale 
change114–116; (iii) communicating the value of the PHC package 
to both municipal and PHC frontline staff117; (iv) identifying and 
adjusting, as appropriate and possible, relevant policies at PHC 
and city levels to expedite the adoption of the PHC package, for 
example by adapting electronic health records; and, (v) identi-
fying gaps in health system performance and the urgent need to 
prevent and manage heavy drinking to promote the needed will and 
energy to bring implementation of the PHC package to scale118. 
The Community Advisory Boards will also identify additional 
mechanisms that can be used to support scale-up, for example: 
(i) development of professional capacity for scale-up; (ii) devel-
opment of infrastructure for scale-up, achieved through redesign 
rather than addition of new resources; (iii) linking to monitoring 
and evaluation, using reliable data collection and reporting sys-
tems that track and provide feedback on the performance of key 
processes and outcomes, for example monthly reporting on 
screening and brief advice activity; (iv) setting up learning 
systems to capture change ideas that are shown to result in 
improved performance assembling ideas into a change package. 
Knowledge should be shared between municipal actors and PHCUs 
through regular electronic newsletters and communications119; 
and, (v) creating design factors that enhance sustainability includ-
ing high reliability of the new processes, inspection systems to 
ensure desired results are being achieved, support for structural 
elements, and ongoing learning systems120,121.
Data collection
Based on the validated methodology of the ODHIN 
project41,122, PHC providers will document activity by com-
pleting paper or electronic (depending on the ability to use 
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existing electronic health records) anonymous tally sheets that 
record eligible patients’ (aged 18+ years) AUDIT-C scores, if 
administered, DSM-5 11-item and PHQ-9 scores, and the advice 
or treatment given to each patient. The tally sheets will record 
the age, sex, employment status, and educational level of the 
patient, the latter as one proxy measure of socio-economic status. 
The tally sheets will also include: two questions that capture pre-
vious experience of being asked about how much the patient 
drinks and of being advised to reduce the amount drunk to pro-
vide information for UN Sustainable Development Goal 3.512; one 
question about alcohol being a cause of high blood pressure, liver 
problems, depression or cancer, as a simple measure of alco-
hol health literacy (knowledge part)123; and, two questions about 
injunctive social norms of drinking alcohol124.
Data will be collected for each calendar month during the 
18-month scale-up period. Formal evaluation will take place dur-
ing three measurement periods: 4-week baseline period; 4-week 
assessment period during the 9th month of the 18-month scale-up 
period; and, 4-week assessment period at 18-months, the end of 
scale-up period. PHCUs will return data on the number of adult 
(aged 18+ years) consultations per provider for the four-week 
baseline assessment period, and for each of the 18 months of the 
scale-up period.
At baseline, PHC providers will provide data on their age, sex 
and profession (doctor, nurse, practice assistant etc.). At baseline, 
and at two time points during the 18-month scale-up period (month 
4.5 and month 13.5), providers will provide data on their alco-
hol health literacy and on their attitudes to working with patients 
with heavy drinking. The alcohol health literacy instrument will 
assess knowledge of risks due to drinking123, and descriptive and 
injunctive social norms124. The attitudes instrument will be the 
shortened version of the Alcohol and Alcohol Problems Perception 
questionnaire125.
During month 3 of the 18-month implementation period, the 
first six consecutive screen positive patients identified by each 
PHC provider will be invited to give their consent to com-
plete two follow-up questionnaires, at six months and twelve 
months after the initial screening. The patient interviews will be 
used for quality control126, but not as a study outcome measure. 
The follow-up questionnaires will be the same as the baseline 
questionnaire and will be undertaken by the local academic unit by 
face-to-face or telephone interview. Collected data will include 
sex, age, educational level, alcohol consumption (operational-
ized by AUDIT-C), alcohol health literacy, prevalence of depres-
sive symptoms using the nine-item patient health questionnaire98, 
experience of screening and brief advice and treatment for heavy 
drinking, experience of self- and co-management for heavy 
drinking and health service utilization.
Process evaluation will be ongoing through interviews with 
CABs, with formal evaluation time points at baseline, ninth month 
of the 18-month scale-up period, and at the end of the scale-up 
period. Logic models will be developed and data will be collected 
on drivers, facilitators and barriers of successful implementation127,128. 
City and country-based contextual, financial and political- 
economy factors will be collected (see outcomes below).
During all phases of the scale-up, we will document impact on 
other sectors (education, social care, criminal and justice, etc.) 
based on resource use measurement129. Patients in the scale-up and 
comparator cities will be asked to complete a short questionnaire 
about resource use measurement. Costs will be calculated by mul-
tiplying volumes (resource use) with unit costs, based on guide-
line prices130. Health and disability will be measured by the WHO 
Disability Assessment Schedule (WHODAS 2.0)131,132. QALYs will 
be derived through transformation of the WHODAS 2.0 12-item 
scores. A probabilistic Markov decision analytic model will be 
built in to estimate the expected cost per outcome and the costs per 
QALY of SCALA from a societal perspective, based on established 
economic evaluation state-transition modelling guidelines133,134. 
Costs and effects will be modelled for five years and life time. 
Probabilistic sensitivity analyses will be executed.
All relevant data required for testing the scale-up will be trans-
ferred to the institution leading the evaluation work (Technische 
Universitaet Dresden) in accordance with its research data 
protocols. No individual data will be published, and data will only 
appear in aggregate form in project publications. On publication of 
the results, datasets will be made available via the UK data archive 
service (http://www.data-archive.ac.uk/).
Outcomes
Primary outcome: The primary outcome will be the proportion of 
consulting adult patients intervened (screened and advice given to 
screen positives), calculated as the number of AUDIT-C positive 
patients that received oral advice or referral for advice to another 
provider in or outside the PHCU, divided by the total number of 
adult consultations of the participating providers per provider and 
per PHCU.
Secondary outcomes: 
-    Screening and advice: The proportion of patients 
screened will be calculated as the number of completed 
screens divided by the total number of consultations of all 
patients eligible for screening (as defined above) per par-
ticipating provider, and averaged per participating PHCU. 
The proportion of patients advised will be calculated as the 
number of brief interventions delivered (received oral brief 
advice, and/or were given an advice leaflet, and/or were 
referred to another provider in or outside the practice), 
divided by the total number of screen positives per par-
ticipating provider and averaged per participating PHCU. 
Information will also be collected on the number of screen 
negatives who received brief advice.
-    Provider attitudes and provider alcohol health literacy:
Attitudes of the participating providers will be measured 
by the short version of the Alcohol and Alcohol Problems 
Perception questionnaire, SAAPPQ25,135–137. The responses 
will be summed within the two scales of role security and 
therapeutic commitment. Individual missing values for 
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any of the items in a domain will be assigned the mean 
value of the remaining items of the domain before sum-
mation. Provider alcohol health literacy will be assessed 
through knowledge of risks due to drinking123, and reported 
descriptive and injunctive social norms of drinking124.
-  Patient alcohol health literacy and injunctive social 
norms: the tally sheets include one question about alco-
hol being a cause of high blood pressure, liver problems, 
depression or cancer, as a simple measure of alcohol 
health literacy (knowledge part)123; and, two questions 
about injunctive social norms of drinking alcohol124. We 
will analyze changes over time from baseline to the end of 
the 18-month implementation period, comparing changes 
in the screened population of alcohol health literacy and 
injunctive social norms between intervention and control 
cities.
Process measures
We will use the RE-AIM Framework as our basis to evaluate 
SCALA’s impact across the five dimensions of reach, efficacy, 
adoption, implementation, and maintenance138–140, ensuring fidelity 
in its completion141, Figure 4.
At least four elements will be included. First, a driver diagram142 
will be used to identify drivers for successful scale-up. To enable 
a nuanced understanding of how scale-up varies in the different 
cities, recognizing that context can have a greater influence on 
scale-up than any pre-specified implementation strategy, the driver 
diagrams will provide real- time continuous feedback on how 
changing contexts in health systems or city actions affect outcomes. 
Second, the evaluation procedure of WHO’s Urban Health Equity 
Assessment and Response Tool (Urban HEART)143 will be modi-
fied to identify the barriers and facilitators to scale-up. Third, the 
factors influencing the progress from scale-up to outcomes will be 
identified and documented based on UK Medical Research Coun-
cil guidance144 analysing factors within five groups: (i) descrip-
tion of intervention and its causal assumptions; (ii) context; 
(iii) implementation; (iv) mechanisms of impact; and, (v) outcomes. 
Fourth, using the detailed methodology of Ysa et al. 145, the experi-
ence and outcomes of the scale-up will be mapped with contex-
tual, financial and political-economy analyses of the cities and the 
countries within which they are located. The following contextual 
factors will be collected: (1) available data similar to that of the 
OECD better life initiative146, including material living conditions 
(housing, income and jobs) and quality of life (community, edu-
cation, environment, governance, health, life satisfaction, safety 
Figure 4. RE-AIM dimension and SCALA aims, activities and main outcome/process measures. PHCU, primary health care unit; PHC, 
primary health care; AUD, alcohol use disorder.
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and work-life balance); (2) Sustainable Governance Indicators147, 
including the Status Index, which ‘examines each state’s reform 
needs in terms of the quality of democracy and performance in 
key policy fields’, and the Management Index, focused on ‘govern-
ance capacities in terms of steering capability and accountability’; 
and, (3) World Values Survey data148,149 for cross-cultural variation 
(Traditional vs. Secular-rational; and, Survival vs. Self-expression). 
Documentation will be complied either at municipal or country 
level for alcohol policy-related strategies, action plans, legislation 
and evaluations. A model will be built on two levels of analyses, 
contextual factors and policy factors and this will be mapped on to 
the test of the scale-up of the PHC interventions to describe and 
identify those contextual and policy factors that might influence 
going to full-scale beyond the implementation cities.
Sample size
Our power calculations are based on the following assumptions: 
at baseline, 2.5/1,000 consulting patients will be found to be 
screen positive (based on an AUDIT-C cut-off score of 8) and 
advised to reduce their alcohol consumption (data from ODHIN 
study; Anderson, personal communication). To detect an increase 
in the number to 5/1,000 (a doubling), with 80% power and a 
significance level of 5%, and assuming a design effect of ten 
PHCUs per three cities per group (scale-up and comparator),  with 
an ICC for PHCUs across countries = 0.03 (data from ODHIN 
study; Anderson, personal communication), a conservative esti-
mate of 30 PHCUs across three scale-up cities and 30 across 
three comparator cities, about ten per city will be needed150, 
assuming an average PHCU size of about 8,000 patients with a 
monthly consultation rate of 1,200 adult patients per PHCU (data 
from ODHIN study; Anderson, personal communication).
Statistical measures
The primary outcome of the study will be the proportion of con-
sulting adult patients intervened (screened and advice given to 
screen positives) measured during two four-week periods mid-
way and at the end of the 18-month scale-up period, and this will 
be analysed at the levels of the PHCU and provider by city type 
(intervention or control)151. Given the rarity of the event and the 
resulting  distribution, we will use exact inference methods for 
comparison of intervention vs. control cities. For further analy-
ses, including covariates, regression models will be used, tak-
ing into consideration the hierarchical nature of the data152, and 
characteristics at different hierarchy levels (i.e., characteristics 
of the PHCU, characteristics at the city level, such as patterns of 
drinking), and incorporating 4-week baseline period measurements 
as covariates. Special consideration will be given to the skew-
ness of data by applying models, such as zero-inflated binomial 
regression, after testing for necessary assumptions153,154. Odds 
ratios will be presented with 95% confidence intervals. For any 
PHCU or provider that drops out during the study, outcome 
values for subsequent measurement points will be set at the last 
value obtained.
Ethics
Before any involvement of participants in the study, including 
patients consulting in the study PHC units, the respective country-
based partner in Colombia, Mexico and Peru will comply with their 
national legislation, regulations and ethical principles by apply-
ing for an ethical approval for research at the competent ethical 
authorities in their jurisdiction.
Discussion
This protocol outlines a quasi-experimental study84 to test the 
extent to which embedding PHC-based screening and brief advice 
activity within supportive municipal action leads to improved 
scale-up of more patients with heavy drinking receiving appropriate 
advice and treatment. 
For a wide range of health care issues, including communica-
ble and non-communicable diseases, as well as reproductive 
and child health care, major variations continue to exist in 
many dimensions of quality of care, including safety, efficiency, 
effectiveness, timeliness, patient centeredness, and equity70. This 
can be understood as a failure to equitably scale up excellent care 
to ensure that what we know works is delivered to everyone who 
needs it.
There is a wealth of literature on implementation science and 
quality improvement, and a range of frameworks exist that include 
a sequential approach for scale-up, and that provide practical 
guidance for how to work with organizations, health systems, and 
communities to implement and scale-up best practices76–83.
In choosing a framework to adopt and apply, we wanted one that 
draws together: the main themes of sequencing activities to get a 
complex health system intervention, with elements of prevention 
and management, to full scale; the mechanisms that are required to 
facilitate the adoption of a complex health system intervention; and, 
the underlying factors and support systems required for successful 
scale-up. We also wanted a framework that includes a scalable unit 
at meso- (in our case city) level that provides the key infrastruc-
tural components and relationship architecture that are likely to be 
common across cities that are part of networks, (e.g., Healthy Cit-
ies Networks) enabling a more likely successful transition to full 
scale.
A key framework that meets all these needs is that of the Institute 
for Healthcare Improvement (IHI) which identifies adoption mech-
anisms and support systems for use across the steps, and identifies 
the implementation methods that can be used at each step, that we 
have incorporated into our protocol70.
The proposed study has several features that merit attention.
First, we simplify and account for cultural differences in defini-
tions of AUD18,19, by using heavy drinking20,21 as our operational 
approach, rather than AUD or harmful use of alcohol1–3.
Second, we set a higher cut-off score for AUDIT-C (8+) 
than is commonly used to classify screened case-positives, 
matching definitions of heavy drinking23,24, and similar to base-
line levels of alcohol consumption in PHC-based trials to reduce 
heavy drinking59. We also set the same cut-offs for men and 
women, based on epidemiological evidence24, and minimizing 
unintended consequences of using different cut offs for men and 
women155.
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Third, we limit brief advice to 5-10 minutes, rather than using 
more intensive interventions67, since the evidence suggests that 
brief advice is as effective and cost-effective as more extended 
advice or treatment in reducing heavy drinking33,34,156,157.
Fourth, we recognize the importance of comorbid moderately 
severe and severe depression65,66, by building in identification and 
referral mechanisms, recognizing that moderately severe and severe 
depression can be well-managed with sufficient support systems in 
PHC67–69.
Fifth, based on evidence71, we adopt a novel approach by embed-
ding and scaling-up the PHC activity within cities, supported by a 
series of city-based adoption mechanisms and support systems70, 
and enhanced alcohol health literacy158, aiming to assist in building 
a new knowledge base, on which better policy could be based.
Sixth, we use a theory-based approach to tailoring100–102, creating 
city-based Community Advisory Boards, and user-based UPs to 
ensure that tailoring matches user needs, municipal services103, and 
co-production of health93,104.
Seventh, we include a range of outcome measures, including 
patient outcomes, as a quality check126, which address weaknesses 
of many previous implementation studies in this area, which have 
focussed on provider outcomes, rather than patient outcomes42,43. 
Through the use of existing electronic health records, and 
further to ethical and confidentiality agreements, we anticipate 
the ability to link individual AUDIT-C scores with consultations 
within the primary health care centers and hospitalizations within 
district hospitals, recording diagnosis for both fully and partially 
attributable alcohol-related conditions13.
Eighth, we have a longer time frame (18 months) than is tradition-
ally used in implementation studies41,44,45,159, to assess longer term 
impacts.
Ninth, we give considerable emphasis to process evaluation144, 
developing logic models to document the fidelity of all implemen-
tation strategies, and to identify, the drivers and barriers and facili-
tators to successful implementation and scale-up, and the political 
and economic contextual factors that might influence scale-up, 
based on the RE-AIM framework138.
And, finally, tenth, we place the study design in the public domain, 
so that others might replicate the study approach (with acknowl-
edgment) to see if the scale-up principles can work across jurisdic-
tions. In so doing, we would be pleased to receive comment and 
feedback.
We are aware of some limitations of the study design. As we 
are unable to randomize the involved cities, we adopt a quasi- 
experimental design, recognizing that it is not possible to randomly 
allocate the municipalities. Randomized selection of the municipal-
ities was excluded as the hypotheses and the study approach relies 
on municipal-level interventions. A trial with random assignments 
of municipalities is not feasible due to cost (number of municipali-
ties) and municipal-based political and technical considerations. 
Randomization of primary health care centers within municipalities 
is also impossible for the same reasons of municipal involvement 
in the interventions. Clean control conditions in this environ-
ment where the municipality supports primary health care-based 
does not seem to be possible. As a result, we created a quasi- 
experimental design84,160,161, trying to optimize control for con-
founding, and using propensity score matching (PSM), given 
the above constraints. While full control via randomization, and 
thus establishment of causality is not possible, together with the 
qualitative evaluation component of the study, we will be 
able to clearly identify the mechanisms which were crucial in 
leading to the outcomes. According to a recent 7-item checklist 
for classifying quasi-experimental studies for Cochrane reviews162, 
our approach is, nevertheless, ranked as a strong design. 
Although our focus on embedding PHC activity within support-
ive municipal actions is hypothesized to increase screening and 
brief activity over and above that previously demonstrated, such 
an approach also brings risks. Municipal governments change; 
and, thus health priorities may change. Although our approach 
minimizes the need for extra resources (and in some jurisdic-
tions, could be resource saving34,40), it is not resource free. Funding 
constraints could limit future scale-up and sustainability.
We have adopted two approaches to promote sustainability. 
First, our protocol is based on transdisciplinary research, which 
is an approach that: identifies, structures, analyses, and deals 
with specific problems in such a way to grasp the complexity of 
problems163; takes into account the diversity of life-world and sci-
entific perceptions of problems; links abstract and case-specific 
knowledge; and, develops knowledge and practices that promote 
what is perceived to be the common good164. As such, we involve 
municipalities as stakeholders to form explicitly orchestrated 
and managed ecosystems that cross organizational boundaries. 
Municipalities will create an appropriate engagement plat-
form that provides the necessary environment, including people 
and resources, for sustainability. Second, we have chosen 
municipalities as the level of scale, making use of the existing 
Latin American and Caribbean (LAC) Healthy Cities Network 
as a natural platform for going to full-scale.
Author contributions
PA, AO’D, EK and JR conceived the study. JR undertook the 
power calculations and wrote the statistical measures. PA drafted 
the manuscript. AO’D, EK, AG, BS, APG, HdV, GNR and 
JR revised the manuscript at all stages of preparation and 
approved the final version.
Competing interests
No competing interests were declared.
Grant information
The study is funded by the European Commission (grant no. 
778048). 
The funders had no role in study design, data collection and 
analysis, decision to publish, or preparation of the manuscript.
Page 13 of 32
F1000Research 2017, 6:311 Last updated: 20 NOV 2017
References
1. Rehm J, Gmel GE Sr, Gmel G, et al.: The relationship between different 
dimensions of alcohol use and the burden of disease-an update. Addiction. 
2017; 112(6):968-1001.  
PubMed Abstract | Publisher Full Text | Free Full Text
2. GBD 2015 Risk Factors Collaborators: Global, regional, and national comparative 
risk assessment of 79 behavioural, environmental and occupational, and 
metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the 
Global Burden of Disease Study 2015. Lancet. 2016; 388(10053): 1659–724. 
PubMed Abstract | Publisher Full Text | Free Full Text
3. World Health Organization (ICD-10).  
Reference Source
4. World Health Organization (ICD-11).  
Reference Source
5. American Psychiatric Association: Diagnostic and Statistical Manual of Mental 
Disorders. Washington, DC, American Psychiatric Association. 2013.  
Reference Source
6. World Health Organization: Global Status Report on Alcohol and Health 2014. 
Geneva, Switzerland: WHO Press, 2014.  
Reference Source
7. Rehm J, Mathers C, Popova S, et al.: Global burden of disease and injury and 
economic cost attributable to alcohol use and alcohol-use disorders. Lancet. 
2009; 373(9682): 2223–2233.  
PubMed Abstract | Publisher Full Text 
8. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators: Global, 
regional and national incidence, prevalence, and years lived with disability 
for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global 
Burden of Disease Study 2015. Lancet. 2016; 388(10053): 1545–1602.  
PubMed Abstract | Publisher Full Text | Free Full Text 
9. Whiteford HA, Ferrari AJ, Degenhardt L, et al.: The Global Burden of Mental, 
Neurological and Substance Use Disorders: An Analysis from the Global 
Burden of Disease Study 2010. PLoS One. 2015; 10(2): e0116820.  
PubMed Abstract | Publisher Full Text | Free Full Text 
10. GBD 2015 Mortality and Causes of Death Collaborators: Global, regional and 
national life expectancy, all-cause mortality, and cause-specific mortality for 
249 causes of death, 1980–2015: a systematic analysis for the Global Burden 
of Disease Study 2015. Lancet. 2016; 388(10053): 1459–1544.  
PubMed Abstract | Publisher Full Text | Free Full Text
11. GBD 2015 DALYs and HALE Collaborators: Global, regional and national 
disability-adjusted life years (DALYs) for 315 diseases and injuries and healthy 
life expectancy (HALE), 1990–2015: a systematic analysis for the Global 
Burden of Disease Study 2015. Lancet. 2016; 388(10053): 1603–1658.  
PubMed Abstract | Publisher Full Text | Free Full Text
12. Allen L, Williams J, Townsend N, et al.: Socioeconomic status and non-
communicable disease behavioural risk factors in low-income and lower-
middle-income countries: a systematic review. Lancet Glob Health. 2017; 5(3): 
e277–89.  
PubMed Abstract | Publisher Full Text 
13. Anderson P, Chisholm D, Fuhr DC: Effectiveness and cost-effectiveness of 
policies and programmes to reduce the harm caused by alcohol. Lancet. 2009; 
373(9682): 2234–2246.  
PubMed Abstract | Publisher Full Text 
14. Kontis V, Mathers CD, Rehm J, et al.: Contribution of six risk factors to 
achieving the 25×25 non-communicable disease mortality reduction target: a 
modelling study. Lancet. 2014; 384(9941): 427–37.  
PubMed Abstract | Publisher Full Text 
15. United Nations General Assembly: Political declaration of the High-level Meeting 
of the General Assembly on the Prevention and Control of Non-communicable 
Diseases. Acessed 01/02/2017.  
Reference Source
16. World Health Organization: Global strategy to reduce the harmful use of alcohol. 
Geneva, Switzerland: World Health Organization; 2010.  
Reference Source
17. United Nations: Sustainable Development Goal 3. Accessed 4 November 2016. 
Reference Source
18. Rehm J: How should prevalence of alcohol use disorders be assessed 
globally? Int J Methods Psychiatr Res. 2016; 25(2): 79–85.  
PubMed Abstract | Publisher Full Text 
19. Rehm J, Room R: Cultural specificity in alcohol use disorders. Lancet. 2015; 
pii: S0140-6736(15)00123-3.  
PubMed Abstract | Publisher Full Text 
20. Rehm J, Marmet S, Anderson P, et al.: Defining substance use disorders: do we 
really need more than heavy use? Alcohol Alcohol. 2013; 48(6): 633–40.  
PubMed Abstract | Publisher Full Text 
21. Rehm J, Anderson P, Gual A, et al.: The Tangible Common Denominator of 
Substance Use Disorders: A Reply to Commentaries to Rehm et al. (2013a). 
Alcohol Alcohol. 2014; 49(1): 118–22.  
PubMed Abstract | Publisher Full Text 
22. European Medicines Agency: Guideline on the development of medicinal 
products for the treatment of alcohol dependence. 2010.  
Reference Source
23. Rehm J, Room R, Monteiro M, et al.: Alcohol Use. In: Comparative quantification 
of health risks: global and regional burden of disease attributable to selected major 
risk factors. Ezzati M et al. (eds), Geneva, Switzerland: World Health Organization. 
2004; 959–1109.  
Reference Source
24. Rehm J, Lachenmeier DW, Room R: Why does society accept a higher risk for 
alcohol than for other voluntary or involuntary risks? BMC Med. 2014; 12: 189. 
PubMed Abstract | Publisher Full Text | Free Full Text 
25. Goldstein MG, Whitlock EP, DePue J, et al.: Multiple behavioral risk factor 
interventions in primary care. Summary of research evidence. Am J Prev Med. 
2004; 27(2 Suppl): 61–79.  
PubMed Abstract | Publisher Full Text 
26. Mhgap Mental Health Gap Action Programme. Scaling Up Care for Mental, 
Neurological, and Substance Use Disorders. 2008.  
Reference Source
27. Kohn R, Saxena S, Levav I, et al.: The treatment gap in mental health care. Bull 
World Health Organ. 2004; 82(11): 858–866.  
PubMed Abstract | Free Full Text 
28. Borges G, Wang PS, Medina-Mora ME, et al.: Delay of first treatment of  
mental and substance use disorders in Mexico. Am J Public Health. 2007;  
97(9): 1638–1643.  
PubMed Abstract | Publisher Full Text | Free Full Text 
29. Medina-Mora ME, Borges G, Benjet C, et al.: Estudio de los trastornos 
mentales en México: resultados de la encuesta mundial de salud mental. En: 
Epidemiología de los trastornos mentales en América Latina y el Caribe. Rodríguez 
JJ, Khon R, Aguilar-Gaxiola S (edit.). Organización Panamericana de la Salud: 
Washington, D.C.: OPS; 2009; 79–89.  
Reference Source
30. Connor JP, Haber PS, Hall WD: Alcohol use disorders. Lancet. 2016; 387(10022): 
988–98.  
PubMed Abstract | Publisher Full Text 
31. Kaner E: Health sector responses. In Alcohol in the European Union: 
consumption, harm and policy approaches. In Anderson P, Møller L & Galea G: 
Copenhagen, Denmark, World Health Organization. 2012.  
Reference Source
32. Rehm J, Shield KD, Gmel G, et al.: Modeling the impact of alcohol dependence 
on mortality burden and the effect of available treatment interventions in the 
European Union. Eur Neuropsychopharmacol. 2013; 23(2): 89–97.  
PubMed Abstract | Publisher Full Text 
33. O’Donnell A, Anderson P, Newbury-Birch D, et al.: The impact of brief alcohol 
interventions in primary healthcare: a systematic review of reviews. Alcohol 
Alcohol. 2014; 49(1): 66–78.  
PubMed Abstract | Publisher Full Text | Free Full Text 
34. Angus C, Latimer N, Preston L, et al.: What are the Implications for Policy Makers? 
A Systematic Review of the Cost-Effectiveness of Screening and Brief 
Interventions for Alcohol Misuse in Primary Care. Front Psychiatry. 2014; 5: 114. 
PubMed Abstract | Publisher Full Text | Free Full Text 
35. Saitz R: The best evidence for alcohol screening and brief intervention in 
primary care supports efficacy, at best, not effectiveness: you say tomāto, I say 
tomăto? That’s not all it’s about. Addict Sci Clin Pract. 2014; 9(1): 14.  
PubMed Abstract | Publisher Full Text | Free Full Text 
36. Magill M, Ray LA: Cognitive-behavioral treatment with adult alcohol and illicit 
drug users: a meta-analysis of randomized controlled trials. J Stud Alcohol 
Drugs. 2009; 70(4): 516–527.  
PubMed Abstract | Publisher Full Text | Free Full Text 
37. Rösner S, Hackl-Herrwerth A, Leucht S, et al.: Acamprosate for alcohol 
dependence. Cochrane Database Syst Rev. 2010; (9): CD004332.  
PubMed Abstract | Publisher Full Text 
38. Rösner S, Hackl-Herrwerth A, Leucht S, et al.: Opioid antagonists for alcohol 
dependence. Cochrane Database Syst Rev. 2010; (12): CD001867.  
PubMed Abstract | Publisher Full Text 
39. Smedslund G, Berg RC, Hammerstrom KT, et al.: Motivational interviewing for 
substance abuse. Cochrane Database Syst Rev. 2011; (5): CD008063.  
PubMed Abstract | Publisher Full Text 
40. Organisation for Economic Co-operation and Development: Tackling Harmful 
Alcohol Use: Economics and Public Health Policy. Paris: Organisation for 
Economic Co-operation and Development. 2015.  
Publisher Full Text 
41. Anderson P, Bendsten P, Spak F, et al.: Improving the delivery of brief 
interventions for heavy drinking in primary health care: outcome results of the 
Optimizing Delivery of Health Care Intervention (ODHIN) five-country cluster 
randomized factorial trial. Addiction. 2016; 111(11): 1935–1945.  
PubMed Abstract | Publisher Full Text 
42. Anderson P, Laurant M, Kaner E, et al.: Engaging general practitioners in the 
management of hazardous and harmful alcohol consumption: results of a 
meta-analysis. J Stud Alcohol. 2004; 65(2): 191–199.  
PubMed Abstract | Publisher Full Text 
43. Keurhorst M, van de Glind I, Bitarello do Amaral-Sabadini M, et al.: Determinants 
of successful implementation of screening and brief interventions for 
hazardous and harmful alcohol consumption in primary healthcare. A 
Page 14 of 32
F1000Research 2017, 6:311 Last updated: 20 NOV 2017
systematic review and meta-regression analysis. Addiction Addiction. 2015; 110: 
877–900. 
44. Anderson P, Gual T, Coulton S, et al.: Improving the delivery of brief 
interventions for heavy drinking in PHC: nine month outcomes of the ODHIN 
five country cluster randomized factorial trial. Ann Fam Med. In Press, 2017. 
Reference Source
45. Anderson P, Kaner E, Wutzke S, et al.: Attitudes and managing alcohol problems 
in general practice: an interaction analysis based on findings from a WHO 
collaborative study. Alcohol Alcohol. 2004; 39(4): 351–356.  
PubMed Abstract | Publisher Full Text 
46. O’Donnell A, Haighton C, Chappel D, et al.: Impact of financial incentives on 
alcohol intervention delivery in primary care: a mixed-methods study. BMC 
Fam Pract. 2016; 17(1): 165.  
PubMed Abstract | Publisher Full Text | Free Full Text 
47. Benegal V, Chand PK, Obot IS: Packages of Care for Alcohol Use Disorders in 
Low- And Middle-Income Countries. PLoS Med. 2009; 6(10): e1000170.  
PubMed Abstract | Publisher Full Text | Free Full Text 
48. Serrano CC, Martínez RD, Mendoza MP, et al.: La intervención eficaz del médico 
general en el tratamiento de bebedores cuyo hábito alcohólico representa un 
riesgo para su salud o ya les ha ocasionado algún daño. (Preliminary results 
of a prospective double blind clinical trial). Salud Mental. 1992; 15(2). 
49. Hoffman KA, Beltrán J, Ponce J, et al.: Barreras para implementar el despistaje, 
intervenciones breves y referencia al tratamiento por problemas de consumo 
de alcohol y otras drogas en hospitales que atienden personas que viven con 
el VIH/SIDA en el Perú. Rev Peru Med Exp Salud Publica. 2016; 33(3): 432–7. 
PubMed Abstract | Publisher Full Text 
50. Gelberg L, Natera Rey G, Andersen RM, et al.: Prevalence of Substance Use 
Among Patients of Community Health Centers in East Los Angeles and 
Tijuana. Subst Use Misuse. 2017; 52(3): 359–372.  
PubMed Abstract | Publisher Full Text 
51. Soto-Brandt G, Portilla Huidobro R, Huepe Artigas D, et al.: [Validity evidence of 
the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) in 
Chile]. Adicciones. 2014; 26(4): 291–302.  
PubMed Abstract | Publisher Full Text 
52. Costa PH, Mota DC, Cruvinel E, et al.: [A methodology to implement preventive 
actions against harmful drug use in the context of primary health care in Latin 
America]. Rev Panam Salud Publica. 2013; 33(5): 325–31.  
PubMed Abstract | Publisher Full Text 
53. Natera R, et al.: Final Narrative Report of the bi-national assist screening and 
quit using drugs intervention trial (quit) Tijuana/Los Angeles. Mexico, National 
Institute on Psychiatry de la Fuente Muniz. 2014. 
54. Kaner E: Brief alcohol intervention: time for translational research. Addiction. 
2010; 105(6): 960–961; discussion 964–5.  
PubMed Abstract | Publisher Full Text 
55. McCambridge J, Saitz R: Rethinking brief interventions for alcohol in general 
practice. BMJ. 2017; 356: j116.  
PubMed Abstract | Publisher Full Text 
56. Jonas DE, Garbutt JC, Brown JM, et al.: Screening, Behavioral Counseling, and 
Referral in Primary Care To Reduce Alcohol Misuse [Internet]. Comparative 
Effectiveness Review No. 64. Rockville MD: Agency for Healthcare Research and 
Quality; 2012; Accessed on 16 April 2016.  
PubMed Abstract 
57. Rubinsky AD, Dawson DA, Williams EC, et al.: AUDIT-C scores as a scaled 
marker of mean daily drinking, alcohol use disorder severity, and probability 
of alcohol dependence in a U.S. general population sample of drinkers. Alcohol 
Clin Exp Res. 2013; 37(8): 1380–1390.  
PubMed Abstract | Publisher Full Text 
58. National Clinical Guideline Centre: The clinical management of primary 
hypertension in adults. 2011; (accessed 1 December 2016).  
Reference Source
59. Kaner EF, Beyer FR, Dickinson HO, et al.: Effectiveness of brief alcohol 
interventions in primary care populations. Cochrane Database Syst Rev. 2007; 
(2): CD004148.  
PubMed Abstract | Publisher Full Text 
60. Platt L, Melendez-Torres GJ, O’Donnell A, et al.: How effective are brief 
interventions in reducing alcohol consumption: do the setting, practitioner 
group and content matter? Findings from a systematic review and 
metaregression analysis. BMJ Open. 2016; 6(8): e011473.  
PubMed Abstract | Publisher Full Text | Free Full Text 
61. Wilson GB, Wray C, McGovern R, et al.: Intervention to reduce excessive 
alcohol consumption and improve comorbidity outcomes in hypertensive or 
depressed primary care patients: two parallel cluster randomized feasibility 
trials. Trials. 2014; 15: 235.  
PubMed Abstract | Publisher Full Text | Free Full Text 
62. Rehm J, Prieto JA, Beier M, et al.: The role of alcohol in the management of 
hypertension in patients in European primary health care practices - a survey 
in the largest European Union countries. BMC Fam Pract. 2016; 17(1): 130. 
PubMed Abstract | Publisher Full Text | Free Full Text 
63. Timko C, Kong C, Vittorio L, et al.: Screening and brief intervention for unhealthy 
substance use in patients with chronic medical conditions: a systematic 
review. J Clin Nurs. 2016; 25(21–22): 3131–3143.  
PubMed Abstract | Publisher Full Text 
64. Coulton S, Dale V, Deluca P, et al.: Screening for At-Risk Alcohol Consumption 
in Primary Care: A Randomized Evaluation of Screening Approaches. Alcohol 
Alcohol. 2017; 52(3): 312–317.  
PubMed Abstract | Publisher Full Text
65. Odlaug BL, Gual A, DeCourcy J, et al.: Alcohol Dependence, Co-occurring 
Conditions and Attributable Burden. Alcohol Alcohol. 2016; 51(2): 201–209. 
PubMed Abstract | Publisher Full Text | Free Full Text 
66. Lai HM, Cleary M, Sitharthan T, et al.: Prevalence of comorbid substance 
use, anxiety and mood disorders in epidemiological surveys, 1990–2014: A 
systematic review and meta-analysis. Drug Alcohol Depend. 2015; 154: 1–13. 
PubMed Abstract | Publisher Full Text 
67. Patel V, Weobong B, Weiss HA, et al.: The Healthy Activity Program (HAP), a lay 
counsellor-delivered brief psychological treatment for severe depression, in 
primary care in India: a randomised controlled trial. Lancet. 2017; 389(10065): 
176–85.  
PubMed Abstract | Publisher Full Text | Free Full Text 
68. Linde K, Sigterman K, Kriston L, et al.: Effectiveness of psychological treatments 
for depressive disorders in primary care: systematic review and meta-
analysis. Ann Fam Med. 2015; 13(1): 56–68.  
PubMed Abstract | Publisher Full Text | Free Full Text 
69. Gilbody S, Whitty P, Grimshaw J, et al.: Educational and organizational 
interventions to improve the management of depression in primary care: a 
systematic review. JAMA. 2003; 289(23): 3145–3151.  
PubMed Abstract | Publisher Full Text 
70. Barker PM, Reid A, Schall MW: A framework for scaling up health interventions: 
lessons from large-scale improvement initiatives in Africa. Implement Sci. 2016; 
11(1): 12.  
PubMed Abstract | Publisher Full Text | Free Full Text 
71. Heather N: WHO Collaborative Project on Identification and Management of 
Alcohol-related Problems in PHC – Report to the World Health Organisation 
on Phase IV: Development of Country-wide Strategies for Implementing Early 
Identification and Brief Intervention in PHC. Geneva: World Health Organisation, 
Department of Mental Health and Substance Abuse: 2006.  
Reference Source
72. Babor T, Del Boca F, Bray JW: Screening, brief intervention and referral to 
treatment: implications of SAMHSA’s SBIRT initiative for substance abuse 
policy and practice. Addiction. 2017; 112(Suppl 2): 110–117.  
PubMed Abstract | Publisher Full Text 
73. Vendetti J, Gmyrek A, Damon D, et al.: Screening, Brief Intervention and 
Referral to Treatment (SBIRT): implementation barriers, facilitators and model 
migration. Addiction. 2017; 112(Suppl 2): 23–33.  
PubMed Abstract | Publisher Full Text 
74. Singh M, Gmyrek A, Hernandez A, et al.: Sustaining Screening, Brief Intervention 
and Referral to Treatment (SBIRT) services in health-care settings. Addiction. 
2017; 112(Suppl 2): 92–100.  
PubMed Abstract | Publisher Full Text 
75. World Bank: World Bank country and lending groups. 2017; Accessed 1 March 
2017.  
Reference Source
76. Eccles M, Grimshaw J, Walker A, et al.: Changing the behavior of healthcare 
professionals: the use of theory in promoting the uptake of research findings. 
J Clin Epidemiol. 2005; 58(2): 107–112.  
PubMed Abstract | Publisher Full Text 
77. Norton W, Mittman B: Scaling-up Health Promotion/Disease Prevention 
Programmes in Community Settings: Barriers, Facilitators, and Initial 
Recommendations. West Hartford, Connecticut, The Patrick and Catherine Weldon 
Donaghue Medical Research Foundation. 2010.  
Reference Source
78. Woolf SH, Johnson RE: The break-even point: when medical advances are less 
important than improving the fidelity with which they are delivered. Ann Fam 
Med. 2005; 3(6): 545–552.  
PubMed Abstract | Publisher Full Text | Free Full Text 
79. Massoud R: An approach to rapid scale-up using HIV/AIDS treatment and care 
as an example. Geneva: World Health Organization; 2004.  
Reference Source
80. Cooley L, Kohl R: Scaling up—from vision to large-scale change: a 
management framework for practitioners. Washington D.C: Management 
Systems International; 2006.  
Reference Source
81. Damschroder LJ, Aron DC, Keith RE, et al.: Fostering implementation of health 
services research findings into practice: a consolidated framework for 
advancing implementation science. Implement Sci. 2009; 4: 50.  
PubMed Abstract | Publisher Full Text | Free Full Text 
82. Yamey G: Scaling up global health interventions: a proposed framework for 
success. PLoS Med. 2011; 8(6): e1001049.  
PubMed Abstract | Publisher Full Text | Free Full Text 
83. Adamou B: Guide for monitoring scale-up of health practices and 
interventions: MEASURE evaluation. 2013; Accessed 4 November 2016. 
Reference Source
84. Shadish WR, Cook TD, Campbell DT: Experimental and quasi-experimental 
designs for generalized causal inference. 2nd edition. Houghton Mifflin, Michigan, 
2002.  
Reference Source
Page 15 of 32
F1000Research 2017, 6:311 Last updated: 20 NOV 2017
85. de Leeuw E, Green G, Spasnwick L, et al.: Policymaking in European healthy 
cities. Health Promot Int. 2015; 30(Suppl 1): i18–i31.  
PubMed Abstract | Publisher Full Text 
86. Farrington JL, Faskunger J, Mackiewicz K: Evaluation of risk factor reduction in a 
European City Network. Health Promot Int. 2015; 30(Suppl 1): i86–i98.  
PubMed Abstract | Publisher Full Text 
87. Mathrani S, Anderson P: Guidelines for city action on alcohol. Copenhagen, 
World Health Organization. 1998.  
Reference Source
88. Giesbrecht N, Bosma LM, Juras J, et al.: Implementing and Sustaining Effective 
Alcohol-Related Policies at the Local Level: Evidence, Challenges, and Next 
Steps. World Med Health Policy. 2014; 6(3): 203–230.  
Publisher Full Text 
89. Goss PE, Lee BL, Badovinac-Crnjevic T, et al.: Planning cancer control in Latin 
America and the Caribbean. Lancet Oncol. 2013; 14(5): 391–436.  
PubMed Abstract | Publisher Full Text 
90. Atun R, de Andrade LO, Almeifda G, et al.: Health-system reform and universal 
health coverage in Latin America. Lancet. 2015; 385(9974): 1230–47.  
PubMed Abstract | Publisher Full Text 
91. Kruk ME, Porignon D, Rockers PC, et al.: The contribution of primary care to 
health and health systems in low- and middle-income countries: a critical 
review of major primary care initiatives. Soc Sci Med. 2010; 70(6): 904–911. 
PubMed Abstract | Publisher Full Text 
92. Cotlear D, Gómez-Dantés O, Knaul F, et al.: Overcoming social segregation in 
health care in Latin America. Lancet. 2015; 385(9947): 1248–59.  
PubMed Abstract | Publisher Full Text 
93. Ngo VK, Rubinstein A, Ganju V, et al.: Grand Challenges: Integrating mental 
health care into the non-communicable disease agenda. PLoS Med. 2013; 
10(5): e1001443.  
PubMed Abstract | Publisher Full Text | Free Full Text 
94. Saloman JA, Carvalho N, Gutiérrez-Delgado C, et al.: Intervention strategies 
to reduce the burden of non-communicable diseases in Mexico: cost 
effectiveness analysis. BMJ. 2012; 344: e355.  
PubMed Abstract | Publisher Full Text | Free Full Text 
95. Poblete F, Barticevic NA, Zuzulic MS, et al.: A randomized controlled trial of a 
brief intervention for alcohol and drugs linked to the Alcohol, Smoking and 
Substance Involvement Screening Test (ASSIST) in primary health care in 
Chile. Addiction. 2017; 112(8): 1462–1469.  
PubMed Abstract | Publisher Full Text 
96. Nadkarni A, Weobong B, Weiss HA, et al.: Counselling for alcohol problems 
(CAP), a lay counsellor-delivered brief psychological treatment for harmful 
drinking in men, in primary care in India: a randomised controlled trial. Lancet. 
2017; 389(10065): 186–195.  
PubMed Abstract | Publisher Full Text | Free Full Text 
97. Hasin DS, O’Brien CP, Auriacombe M, et al.: DSM-5 criteria for substance use 
disorders: recommendations and rationale. Am J Psychiatry. 2013; 170(8): 
834–851.  
PubMed Abstract | Publisher Full Text | Free Full Text 
98. Patel V, Araya R, Chowdhary N, et al.: Detecting common mental disorders in 
primary care in India: a comparison of five screening questionnaires. Psychol 
Med. 2008; 38(2): 221–28.  
PubMed Abstract | Publisher Full Text | Free Full Text 
99. Hester RK, Miller WR: Handbook of Alcoholism Treatment Approaches. 2 ed. 
Boston MA: 1995.  
Reference Source
100. Wensing M, Oxman A, Baker R, et al.: Tailored Implementation For Chronic 
Diseases (TICD): a project protocol. Implement Sci. 2011; 6: 103.  
PubMed Abstract | Publisher Full Text | Free Full Text 
101. Wensing M, Huntink E, van Lieshout J, et al.: Tailored Implementation of Evidence-
Based Practice for Patients with Chronic Diseases. PLoS One. 2014; 9(7): e101981. 
PubMed Abstract | Publisher Full Text | Free Full Text 
102. Flottorp SA, Oxman AD, Krause J, et al.: A checklist for identifying determinants 
of practice: a systematic review and synthesis of frameworks and taxonomies 
of factors that prevent or enable improvements in healthcare professional 
practice. Implement Sci. 2013; 8: 35.  
PubMed Abstract | Publisher Full Text | Free Full Text 
103. Dietz WH, Solomon LS, Pronk N, et al.: An Integrated Framework For The 
Prevention And Treatment Of Obesity And Its Related Chronic Diseases.  
Health Aff (Millwood). 2015; 34(9): 1456–1463.  
PubMed Abstract | Publisher Full Text 
104. Palumbo R: Contextualizing co-production of health care: a systematic 
literature review. Int J Public Se Manage. 2016; 29(1): 72–90.  
Publisher Full Text 
105. Babor TF, Higgins-Biddle JC, Higgins PS, et al.: Training medical providers to 
conduct alcohol screening and brief interventions. Subst Abus. 2004; 25(1): 
17–26.  
PubMed Abstract | Publisher Full Text | Free Full Text 
106. Fleming MF: Strategies to increase alcohol screening in health care settings. 
Alcohol Health Res World. 1997; 21(4): 340–7.  
PubMed Abstract 
107. Davis DA, Thomson MA, Oxman AD, et al.: Changing physician performance. 
A systematic review of the effect of continuing medical education strategies. 
JAMA. 1995; 274(9): 700–705.  
PubMed Abstract | Publisher Full Text 
108. Fleming MF: Screening and brief intervention in primary care settings. Alcohol 
Res Health. 2004–2005; 28(2): 57–62.  
PubMed Abstract 
109. Garzonis K, Mann E, Wyrzykowska A, et al.: Improving patient outcomes: 
effectively training healthcare staff in psychological practice skills: a mixed 
systematic literature review. Eur J Psychol. 2015; 11(3): 535–56.  
PubMed Abstract | Publisher Full Text | Free Full Text 
110. Nilsen P, Wåhlin S, Heather N: Implementing brief interventions in health care: 
lessons learned from the Swedish risk drinking project. Int J Environ Res Public 
Health. 2011; 8(9): 3609–3627.  
PubMed Abstract | Publisher Full Text | Free Full Text 
111. Patterson Silver Wolf Adelv Unegv Waya DA: Factors influencing the 
implementation of a brief alcohol screening and educational intervention in 
social settings not specializing in addiction services. Soc Work Health Care. 
2015; 54(4): 345–364.  
PubMed Abstract | Publisher Full Text | Free Full Text 
112. May CR, Johnson M, Finch T: Implementation, context and complexity. 
Implement Sci. 2016; 11(4): 141.  
PubMed Abstract | Publisher Full Text | Free Full Text 
113. Gual A, Anderson P, Segura L, et al.: Alcohol and Primary hrealth care: Training 
programme on identification and brief interventions. Barcelona: department of 
Health of the Government of Catalonia, 2005.  
Reference Source
114. McCannon CJ, Perla RJ: Learning networks for sustainable, large-scale 
improvement. Jt Comm J Qual Patient Saf. 2009; 35(5): 286–91.  
PubMed Abstract | Publisher Full Text 
115. Reinertsen JL, Bisognano M, Pugh MD: Seven leadership leverage points for 
organization-level improvement in health care. (second edition) (IHI innovation 
series white paper). Cambridge: Institute for Healthcare Improvement; 2008. 
Reference Source
116. Swenson S, Pugh M, McMullan C, et al.: Book high impact leadership: improve 
care, improve the health of populations, and reduce costs. (IHI white paper). 
Cambridge: Institute for Healthcare Improvement; 2013.  
Reference Source
117. Rogers E: Diffusion of innovations. 5th ed. New York: The Free Press; 2003. 
Reference Source
118. McCannon CJ, Schall MW, Perla RJ: Planning for scale: a guide for designing 
large-scale improvement initiatives. (IHI innovation series white paper). 
Cambridge: Institute for Healthcare Improvement; 2008.  
Reference Source
119. Schouten LM, Hulscher ME, van Everdingen JJ, et al.: Evidence for the impact of 
quality improvement collaboratives: systematic review. BMJ. 2008; 336(7659): 
1491–4.  
PubMed Abstract | Publisher Full Text | Free Full Text 
120. NHS Modernisation Agency: Improvement leaders guide to sustainability and 
spread. Ipswich: Ancient House Printing Group; 2002.  
Reference Source
121. Mate K, Sifrim Z, Provost L: Sustainability of improvement interventions (IHI 
90-day R&D project final summary report). Cambridge: Institute for Healthcare 
Improvement; 2011.




factorial trial. Implement Sci. 2013; 8: 11.  
PubMed Abstract | Publisher Full Text | Free Full Text 
123. Sørensen K, Van den Broucke S, Pelikan JM, et al.: Measuring health literacy 
in populations: illuminating the design and development process of the 
European Health Literacy Survey Questionnaire (HLS-EU-Q). BMC Public 
Health. 2013; 13: 948.  
PubMed Abstract | Publisher Full Text | Free Full Text 
124. Chung A, Rimal RN: Social norms: A review. Review of Communication Research. 
2016; 4: 1–29.  
Publisher Full Text 
125. Anderson P, Clement S: The AAPPQ revisited: the measurement of general 
practitioners’ attitudes to alcohol problems. Br J Addict. 1987; 82(7):  
753–9.  
PubMed Abstract | Publisher Full Text 
126. Vendetti JA, McRee BG, Del Boca FK: Development of the SBIRT checklist for 
observation in real-time (SCORe). Addiction. 2017; 112(Suppl 2): 34–42.  
PubMed Abstract | Publisher Full Text 
127. Del Boca FK, McRee B, Vendetti J, et al.: The SBIRT program matrix: a 
conceptual framework for program implementation and evaluation. Addiction. 
2017; 112(Suppl 2): 12–22.21.  
PubMed Abstract | Publisher Full Text 
128. Bray JW, Del Boca FK, McRee BG, et al.: Screening, Brief Intervention and 
Referral to Treatment (SBIRT): rationale, program overview and cross-site 
evaluation. Addiction. 2017; 112(Suppl 2): 3–11.  
PubMed Abstract | Publisher Full Text 
129. Thorn JC, Coast J, Cohen D, et al.: Resource-use measurement based on 
Page 16 of 32
F1000Research 2017, 6:311 Last updated: 20 NOV 2017
patient recall: issues and challenges for economic evaluation. Appl Health Econ 
Health Policy. 2013; 11(3): 155–161.  
PubMed Abstract | Publisher Full Text 
130. Drost RM, Paulus AT, Ruwaard D, et al.: Valuing inter-sectoral costs and 
benefits of interventions in the healthcare sector: methods for obtaining unit 
prices. Expert Rev Pharmacoecon Outcomes Res. 2017; 17(1): 77–84.  
PubMed Abstract | Publisher Full Text 
131. Üstün TB, Chatterji S, Kostanjsek N, et al.: Developing the World Health 
Organization Disability Assessment Schedule 2.0. Bull World Health Organ. 
2010; 88(11): 815–23.  
PubMed Abstract | Publisher Full Text | Free Full Text 
132. Measuring Health and Disability: Manual for WHO Disability Assessment 
Schedule (WHODAS 2.0). edited by TB Üstün, N Kostanjsek, S Chatterji, J Rehm, 
Geneva. World Health Organization. 2010.  
Reference Source
133. Briggs A, Claxton K, Sculpher MJ: Decision Modelling for Health Economic 
Evaluation. Oxford University Press, Oxford. 2006.  
Reference Source
134. Caro JJ, Briggs AH, Siebert U, et al.: Modeling good research practices--
overview: a report of the ISPOR-SMDM Modeling Good Research Practices 
Task Force--1. Value Health. 2012; 15(6): 796–803.  
PubMed Abstract | Publisher Full Text 
135. Anderson P, Kaner E, Wutzke S, et al.: Attitudes and management of alcohol 
problems in general practice: descriptive analysis based on findings of a 
World Health Organization international collaborative survey. Alcohol Alcohol. 
2003; 38(6): 597–601.  
PubMed Abstract | Publisher Full Text 
136. Anderson P, Wojnar M, Jakubczyk A, et al.: Managing alcohol problems in 
general practice in Europe: results from the European ODHIN survey of 
general practitioners. Alcohol Alcohol. 2014; 49(5): 531–539.  
PubMed Abstract | Publisher Full Text 
137. Anderson P, Kaner E, Keurhorst M, et al.: Attitudes and Learning through 
Practice Are Key to Delivering Brief Interventions for Heavy Drinking 
in Primary Health Care: Analyses from the ODHIN Five Country Cluster 
Randomized Factorial Trial. Int J Environ Res Public Health. 2017; 14(2):  
pii: E121. 
PubMed Abstract | Publisher Full Text | Free Full Text 
138. Glasgow RE, Vogt TM, Boles SM: Evaluating the public health impact of health 
promotion interventions: the RE-AIM framework. Am J Public Health. 1999; 
89(9): 1322–7.  
PubMed Abstract | Publisher Full Text | Free Full Text 
139. Glasgow RE, Klesges LM, Dzewaltowski DA, et al.: Evaluating the impact of 
health promotion programs: using the RE-AIM framework to form summary 
measures for decision making involving complex issues. Health Educ Res. 
2006; 21(5): 688–694.  
PubMed Abstract | Publisher Full Text 
140. Gaglio B, Shoup JA, Glasgow RE: The RE-AIM framework: a systematic review 
of use over time. Am J Public Health. 2013; 103(6): e38–e46.  
PubMed Abstract | Publisher Full Text | Free Full Text 
141. Harden SM, Gaglio B, Shoup JA, et al.: Fidelity to and comparative results 
across behavioral interventions evaluated through the RE-AIM framework: a 
systematic review. Syst Rev. 2015; 4: 155.  
PubMed Abstract | Publisher Full Text | Free Full Text 
142. Svoronos T, Mate KS: Evaluating large-scale health programmes at a district 
level in resource-limited countries. Bull World Health Organ. 2011; 89(11):  
831–837.  
PubMed Abstract | Publisher Full Text | Free Full Text 
143. Prasad A, Kano M, Dagg KA, et al.: Prioritizing action on health inequities in 
cities: An evaluation of Urban Health Equity Assessment and Response Tool 
(Urban HEART) in 15 cities from Asia and Africa. Soc Sci Med. 2015; 145: 
237–242.  
PubMed Abstract | Publisher Full Text | Free Full Text
144. Moore GF, Audrey S, Barker M, et al.: Process evaluation of complex 
interventions: Medical Research Council guidance. BMJ. 2015; 350: h1258. 
PubMed Abstract | Publisher Full Text | Free Full Text 
145. Ysa T, Colom J, Albareda A, et al.: Governance of Addictions. European Public 
Policies. Oxford University Press, 2014.  
Reference Source
146. OECD: Compendium of OECD well-being indicators. OECD Better Life 
Initiative. 2011; (Accessed 18 December 2016).  
Reference Source
147. Bertelsmann Stiftung. [website]. 2016; (Accessed 18 December 2016). 
Reference Source
148. Inglehart R, Welzel C: Modernization, Cultural Change and Democracy. New 
York: Cambridge University Press, 2005.  
Reference Source
149. Inglehart R, Welzel C: Changing Mass Priorities: The Link Between 
Modernization and Democracy. Perspect Polit. 2010; 8(2): 551–567.  
Publisher Full Text 
150. Donner A, Klar N: Design and Analysis of Cluster Randomization Trials in 
Health Research. Arnold, London. 2000. 
Reference Source
151. Fleiss JL, Levin B, Cho Paik M: Statistical Methods for Rates and Proportions. 
Third Edition. Hoboken, New Jersey: John Wiley & Sons, 2003.  
Reference Source
152. Raudenbush SW, Bryk AS: Hierarchical Linear Models. Applications and Data 
Analysis Methods. 2002; 2: Sage Publications.  
Reference Source
153. Hall DB: Zero-inflated Poisson and binomial regression with random effects: a 
case study. Biometrics. 2000; 56(4): 1030–1039.  
PubMed Abstract | Publisher Full Text 
154. Zuur AF, Ieno EN, Walker NJ, et al.: Mixed effects models and extensions in 
ecology with R. New York, NY: Springer, 2009. 
Publisher Full Text
155. Cunningham JA: Unintended impact of using different inclusion cut-offs for 
males and females in intervention trials for hazardous drinking. Addiction. 2017; 
112(5): 910–911.  
PubMed Abstract | Publisher Full Text 
156. Aldridge A, Dowd W, Bray J: The relative impact of brief treatment versus brief 
intervention in primary health-care screening programs for substance use 
disorders. Addiction. 2017; 112(Suppl 2): 54–64.  
PubMed Abstract | Publisher Full Text 
157. Barbosa C, Cowell A, Dowd W, et al.: The cost-effectiveness of brief intervention 
versus brief treatment of screening, brief intervention, and referral to 
treatment (SBIRT) in the United States. Addiction. 2017; 112(Suppl 2): 73–81.  
PubMed Abstract | Publisher Full Text 
158. Beauchamp A, Batterham RW, Dodson S, et al.: Systematic development and 
implementation of interventions to OPtimise Health Literacy and Access 
(Ophelia). BMC Public Health. 2017; 17: 230.  
PubMed Abstract | Publisher Full Text | Free Full Text 
159. Funk M, Wutzke S, Kaner E, et al.: A multicountry controlled trial of strategies 
to promote dissemination and implementation of brief alcohol intervention 
in primary health care: findings of a World Health Organization collaborative 
study. J Stud Alcohol. 2005; 66(3): 379–388.  
PubMed Abstract | Publisher Full Text 
160. Campbell DT, Stanley JC: Experimental and quasi-experimental designs for 
research. Chicago, Illinois: Rand McNally, 1963.  
Reference Source
161. Cook TD, Campbell DT: Quasi-experimentation: design and analysis for field 
settings. Boston: Houghton Mifflin Company; 1979.  
Reference Source
162. Reeves BC, Wells GA, Waddington H: Quasi-experimental study designs series-
paper 5: classifying studies evaluating effects of health interventions-a taxonomy 
without labels. J Clin Epidemiol. 2017; 89: 30–42. pii: S0895-4356(17)30288-3.  
PubMed Abstract | Publisher Full Text 
163. Jantsch E: Inter- and Transdisciplinary University: A systems approach to 
education and innovation. Policy Sciences. 1970; 1(1): 403–428.  
Publisher Full Text
164. Pohl C, Hirsch Hadorn G: Principles for Designing Transdisciplinary Research. 
proposed by the Swiss Academies of Arts and Sciences. München: oekom Verlag. 
2007.  
Reference Source
Page 17 of 32
F1000Research 2017, 6:311 Last updated: 20 NOV 2017
 
Open Peer Review
   Current Referee Status:
Version 3






I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard.







I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard.
Version 2






Page 18 of 32



















Is the rationale for, and objectives of, the study clearly described?
Yes
Is the study design appropriate for the research question?
Yes
Are sufficient details of the methods provided to allow replication by others?
Yes
Are the datasets clearly presented in a useable and accessible format?
Yes
 No competing interests were disclosed.Competing Interests:
I have read this submission. I believe that I have an appropriate level of expertise to confirm that












Page 19 of 32
































1. Reviewer’s abbreviated comment on original version
The introduction starts awkwardly with a description of the alternative ways of conceptualising
alcohol misuse. For the definitive version of the paper, I would strongly suggest that the relevant





Page 20 of 32
F1000Research 2017, 6:311 Last updated: 20 NOV 2017
 























2. Reviewer’s abbreviated comment on original version











3. Reviewer’s abbreviated comment on original version
Is there any work reported for the three countries selected on the professional supports
available to PHC staff? 
Page 21 of 32
F1000Research 2017, 6:311 Last updated: 20 NOV 2017
 




Reviewer’s comments on this response
The revisions address this comment.
4. Reviewer’s abbreviated comment on original version
Reference is made to various scaling-up approaches but the paper would be strengthened by a
description and discussion of the theoretical concepts underlying the framework proposed. 
Authors’ response
We have added text on implementation and scale-up literature to the first part of the discussion.
Reviewer’s comments on this response
The revisions address this comment.
5. Reviewer’s abbreviated comment on original version
Will the investigators have access to medical records and PHC throughput data?
Author's response
In all three countries, electronic health records are used. Provided...
Reviewer’s comments on this response
The revisions address this comment.
6. Reviewer’s abbreviated comment on original version
Overall, this is a very ambitious and complex research program and I became concerned in
reading it - in all its complexity - that it might not be achievable with staff who have no prior










Page 22 of 32






















7. Reviewer’s abbreviated comment on original version
There is a statement “During all phases of the scale-up, we will document impact on other
sectors (education, social care, criminal and justice, etc.) base on resource use measurement.” 








8. Reviewer’s abbreviated comment on original version




Reviewer’s comments on this response
I would hope not, but the onus is also to provide sufficient information to convince an independent
Page 23 of 32








9. Reviewer’s abbreviated comment on original version
Although there are approximately 160 references, an impressive number for a protocol paper,




Reviewer’s comments on this response
The revisions address this comment.
 No competing interests were disclosed.Competing Interests:
I have read this submission. I believe that I have an appropriate level of expertise to confirm that




1. Reviewer’s abbreviated comment on original version
The introduction starts awkwardly with a description of the alternative ways of
conceptualising alcohol misuse. For the definitive version of the paper, I would strongly











2. Reviewer’s abbreviated comment on original version




Reviewer’s comments on this response
It is true – check the NESARC data. I entirely accept the rationale for...
Page 24 of 32
F1000Research 2017, 6:311 Last updated: 20 NOV 2017
 




3. Reviewer’s abbreviated comment on original version
Is there any work reported for the three countries selected on the professional supports








4. Reviewer’s abbreviated comment on original version
Reference is made to various scaling-up approaches but the paper would be strengthened








5. Reviewer’s abbreviated comment on original version
Will the investigators have access to medical records and PHC throughput data?
In all three countries, electronic health records are used. Provided ethical and confidentiality
agreements...




6. Reviewer’s abbreviated comment on original version
Overall, this is a very ambitious and complex research program and I became concerned
in reading it - in all its complexity - that it might not be achievable with staff who have no












7. Reviewer’s abbreviated comment on original version
There is a statement “During all phases of the scale-up, we will document impact on other
sectors (education, social care, criminal and justice, etc.) base on resource use
measurement.”  This is a huge additional amount of work.
Page 25 of 32
F1000Research 2017, 6:311 Last updated: 20 NOV 2017
 
measurement.”  This is a huge additional amount of work.
Authors’ response
This is a misunderstanding. It requires quite minimal data collection...




8. Reviewer’s abbreviated comment on original version











9. Reviewer’s abbreviated comment on original version
Although there are approximately 160 references, an impressive number for a protocol
























Page 26 of 32





















Is the rationale for, and objectives of, the study clearly described?
Yes
Is the study design appropriate for the research question?
Partly
Are sufficient details of the methods provided to allow replication by others?
Partly





I have read this submission. I believe that I have an appropriate level of expertise to confirm that




It is quite unclear how the authors intend to maintain the interventions after the project
Page 27 of 32
F1000Research 2017, 6:311 Last updated: 20 NOV 2017
 




















It is unclear how the participating cities will be chosen and how the intervention city will
be chosen. Including three different “cultures” with only one intervention and one control






















Page 28 of 32




























































Page 29 of 32









Findings of a World Health Organization Collaborative Study.   2005;Journal of Studies on Alcohol
66: 379-388. 
Is the rationale for, and objectives of, the study clearly described?
Yes
Is the study design appropriate for the research question?
Yes
Are sufficient details of the methods provided to allow replication by others?
Partly







I have read this submission. I believe that I have an appropriate level of expertise to confirm that




The introduction starts awkwardly with a description of the alternative ways of
conceptualising alcohol misuse. For the definitive version of the paper, I would strongly











Page 30 of 32
















Is there any work reported for the three countries selected on the professional supports










Reference is made to various scaling-up approaches but the paper would be strengthened










Overall, this is a very ambitious and complex research program and I became concerned
in reading it - in all its complexity - that it might not be achievable with staff who have no











There is a statement “During all phases of the scale-up, we will document impact on other
Page 31 of 32
F1000Research 2017, 6:311 Last updated: 20 NOV 2017
 
There is a statement “During all phases of the scale-up, we will document impact on other
sectors (education, social care, criminal and justice, etc.) base on resource use










Although there are approximately 160 references, an impressive number for a protocol












Page 32 of 32
F1000Research 2017, 6:311 Last updated: 20 NOV 2017
